CYCS-related thrombocytopenia (thrombocytopenia 4, THC4) is an autosomal-dominant inherited thrombocytopenia caused by heterozygous missense variants in CYCS, the nuclear gene encoding somatic cytochrome c. Public disease sources anchor OMIM:612004 and ORPHA:168629 to this thrombocytopenia entity, not to a cytochrome c oxidase holoenzyme-assembly disorder. The disease is mechanistically mitochondrial because cytochrome c transfers electrons in the respiratory chain and participates in intrinsic apoptosis, but the dominant clinical phenotype is mild-to-moderate isolated thrombocytopenia with normal platelet size and low bleeding risk. Model and patient-cell data support a dual mechanism: CYCS variants reduce respiratory performance and increase apoptotic activity, while megakaryocyte-bone-marrow interactions promote premature platelet-like release into extravascular marrow space, lowering circulating platelet number.
Ask a research question about CYCS-Related Thrombocytopenia. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: CYCS-Related Thrombocytopenia
category: Mendelian
creation_date: "2026-07-06T01:49:38Z"
synonyms:
- Thrombocytopenia 4
- THC4
- CYCS thrombocytopenia
- Autosomal dominant non-syndromic thrombocytopenia 4
- Autosomal isolated thrombocytopenia with normal platelet size
description: >-
CYCS-related thrombocytopenia (thrombocytopenia 4, THC4) is an
autosomal-dominant inherited thrombocytopenia caused by heterozygous missense
variants in CYCS, the nuclear gene encoding somatic cytochrome c. Public
disease sources anchor OMIM:612004 and ORPHA:168629 to this thrombocytopenia
entity, not to a cytochrome c oxidase holoenzyme-assembly disorder. The
disease is mechanistically mitochondrial because cytochrome c transfers
electrons in the respiratory chain and participates in intrinsic apoptosis,
but the dominant clinical phenotype is mild-to-moderate isolated
thrombocytopenia with normal platelet size and low bleeding risk. Model and
patient-cell data support a dual mechanism: CYCS variants reduce respiratory
performance and increase apoptotic activity, while megakaryocyte-bone-marrow
interactions promote premature platelet-like release into extravascular marrow
space, lowering circulating platelet number.
classifications:
icimd_category:
- classification_value: cytochrome_c
notes: >-
WP-023 / ICIMD code 8.3.03.01 places this seed under disorders of
mitochondrial cytochrome c. The curated DisMech disease identity follows
MONDO:0012775 / OMIM:612004 as CYCS-related thrombocytopenia; it is kept
separate from the Complex IV deficiency grouping because CYCS encodes the
soluble electron carrier cytochrome c rather than a COX structural subunit
or assembly factor.
disease_term:
preferred_term: CYCS-related thrombocytopenia (THC4)
term:
id: MONDO:0012775
label: thrombocytopenia 4
mappings:
mondo_mappings:
- term:
id: MONDO:0012775
label: thrombocytopenia 4
mapping_predicate: skos:exactMatch
mapping_source: MONDO
mapping_justification: >-
MONDO:0012775 is defined as thrombocytopenia caused by mutation in CYCS
and carries the OMIM:612004 cross-reference for thrombocytopenia 4.
parents:
- Inherited thrombocytopenia
- Mitochondrial Disease
external_assertions:
- name: Orphanet CYCS disease-gene record
source: Orphanet
assertion_type: disease_gene_record
external_id: ORPHA:168629
url: https://www.orpha.net/en/disease/detail/168629
description: >-
Orphanet identifies ORPHA:168629 as autosomal isolated thrombocytopenia with
normal platelet size and links CYCS as a disease-causing germline gene.
prevalence:
- population: Reported CYCS families
measure_type: CASES_IN_LITERATURE
prevalence_class: ULTRA_RARE
notes: >-
Published cohorts describe THC4 as extremely rare, with only a few families
reported before the 2024 expansion series.
evidence:
- reference: PMID:38815995
reference_title: "Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "THC4 is considered an extremely rare condition since only a few patients have been reported so far."
explanation: The 2024 cohort review supports an ultra-rare, cases-in-literature prevalence characterization.
inheritance:
- name: Autosomal dominant inheritance
description: >-
THC4 is caused by monoallelic heterozygous CYCS variants segregating with
thrombocytopenia in affected pedigrees.
inheritance_term:
preferred_term: Autosomal dominant inheritance
term:
id: HP:0000006
label: Autosomal dominant inheritance
evidence:
- reference: PMID:38815995
reference_title: "Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Thrombocytopenia 4 (THC4) is an autosomal-dominant thrombocytopenia caused by mutations in CYCS"
explanation: Establishes autosomal-dominant inheritance for CYCS-related thrombocytopenia.
pathophysiology:
- name: CYCS Missense Variant Alters Cytochrome c
role: trigger
description: >-
Heterozygous missense variants in CYCS alter somatic cytochrome c, a small
mitochondrial heme protein that shuttles electrons in oxidative
phosphorylation and also participates in intrinsic apoptotic signaling after
mitochondrial release.
gene:
preferred_term: CYCS
term:
id: hgnc:19986
label: CYCS
biological_processes:
- preferred_term: respiratory electron transport chain
term:
id: GO:0022904
label: respiratory electron transport chain
modifier: DECREASED
- preferred_term: intrinsic apoptotic signaling pathway
term:
id: GO:0097193
label: intrinsic apoptotic signaling pathway
modifier: INCREASED
evidence:
- reference: PMID:38815995
reference_title: "Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Thrombocytopenia 4 (THC4) is an autosomal-dominant thrombocytopenia caused by mutations in CYCS, the gene encoding cytochrome c (CYCS), a small haeme protein essential for electron transport in mitochondria and cell apoptosis."
explanation: Identifies CYCS as the causal gene and cytochrome c as an electron-transfer and apoptosis protein.
downstream:
- target: Reduced Respiration and Increased Apoptotic Activity
causal_link_type: DIRECT
description: >-
CYCS variants alter both electron-transfer/bioenergetic behavior and
apoptotic activity of cytochrome c.
- name: Reduced Respiration and Increased Apoptotic Activity
role: central_effector
description: >-
Functional studies of thrombocytopenia-associated CYCS variants show reduced
respiratory performance alongside increased apoptotic activity. This
distinguishes CYCS-related thrombocytopenia from classic Complex IV
assembly deficiency: cytochrome c is affected, but patients generally do not
show a syndromic cytochrome c oxidase deficiency phenotype.
cell_types:
- preferred_term: megakaryocyte
term:
id: CL:0000556
label: megakaryocyte
biological_processes:
- preferred_term: respiratory electron transport chain
term:
id: GO:0022904
label: respiratory electron transport chain
modifier: DECREASED
- preferred_term: positive regulation of apoptotic process
term:
id: GO:0043065
label: positive regulation of apoptotic process
modifier: INCREASED
evidence:
- reference: PMID:24326104
reference_title: "Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergetics."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "we found reduction of respiratory level and increased apoptotic rate, supporting the pathogenetic role of CYCS in thrombocytopenia."
explanation: Yeast and mouse cellular models directly support reduced respiration and increased apoptosis downstream of thrombocytopenia-associated CYCS variants.
- reference: PMID:18345000
reference_title: "A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "The mutation yields a cytochrome c variant with enhanced apoptotic activity in vitro."
explanation: The original CYCS G41S study supports enhanced apoptotic activity as a variant effect.
downstream:
- target: Dysregulated Megakaryocyte Platelet Release
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
intermediate_mechanisms:
- altered cytochrome c respiratory function
- enhanced intrinsic apoptotic signaling
description: >-
Altered cytochrome c function perturbs megakaryocyte platelet-release
behavior, with premature platelet-like release in the marrow space.
- name: Dysregulated Megakaryocyte Platelet Release
role: central_effector
description: >-
Patient studies indicate that circulating proplatelet formation can remain
effective, but CYCS-mutant megakaryocytes also release platelet-like
structures prematurely into extravascular bone marrow regions. Platelet-like
structures released outside the vascular space lack a normal marginal
microtubule coil, making them ineffective contributors to the circulating
platelet pool.
cell_types:
- preferred_term: megakaryocyte
term:
id: CL:0000556
label: megakaryocyte
- preferred_term: platelet
term:
id: CL:0000233
label: platelet
biological_processes:
- preferred_term: platelet formation
term:
id: GO:0030220
label: platelet formation
evidence:
- reference: PMID:27861742
reference_title: "Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "the low platelet phenotype in Thrombocytopenia Cargeeg subjects is caused by premature release of platelets into non-vascular regions of the bone marrow."
explanation: Patient marrow observations support premature extravascular platelet release as a mechanism for low circulating platelet count.
- reference: PMID:27861742
reference_title: "Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "platelet-like structures within the extravascular bone marrow space have the dimensions of platelets but lack the marginal microtubule coil, suggesting abnormal proplatelet-independent platelet release."
explanation: The abnormal extravascular platelet-like structures provide a tissue-level link from CYCS-mutant megakaryocytes to reduced effective platelet production.
downstream:
- target: Thrombocytopenia
causal_link_type: DIRECT
description: >-
Premature or misplaced platelet-like release reduces the number of mature
platelets reaching the circulation.
phenotypes:
- name: Thrombocytopenia
category: Hematologic
description: >-
Mild-to-moderate isolated thrombocytopenia with normal platelet size and
generally low bleeding risk.
phenotype_term:
preferred_term: Thrombocytopenia
term:
id: HP:0001873
label: Thrombocytopenia
evidence:
- reference: PMID:38815995
reference_title: "Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "mild-to-moderate thrombocytopenia, normal platelet size, and function, low risk of bleeding, and no additional clinical phenotypes associated with reduced platelet count."
explanation: The largest reported THC4 cohort defines the characteristic platelet phenotype.
- reference: PMID:35126455
reference_title: "A Novel Heterozygous Pathogenic Variation in CYCS Gene Cause Autosomal Dominant Non-Syndromic Thrombocytopenia 4 in a Large Chinese Family."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The platelet counts of the patients were varied, ranging from 38 to 110 × 109/L (reference range: 150-450 x 109/L)."
explanation: A three-generation CYCS family documents reduced platelet counts in affected individuals.
genetic:
- name: CYCS pathogenic variants causing thrombocytopenia 4
gene_term:
preferred_term: CYCS
term:
id: hgnc:19986
label: CYCS
inheritance:
- name: Autosomal dominant
evidence:
- reference: PMID:35126455
reference_title: "A Novel Heterozygous Pathogenic Variation in CYCS Gene Cause Autosomal Dominant Non-Syndromic Thrombocytopenia 4 in a Large Chinese Family."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "A novel heterozygous missense variant c.79C > T (p.His27Tyr) was identified in CYCS gene associated with autosomal dominant thrombocytopenia."
explanation: A heterozygous CYCS missense variant segregated with autosomal-dominant thrombocytopenia in a three-generation family.
variants:
- name: CYCS p.Gly41Ser
description: >-
The original New Zealand family variant; it alters cytochrome c and
enhances intrinsic apoptotic activity in vitro.
gene:
preferred_term: CYCS
term:
id: hgnc:19986
label: CYCS
evidence:
- reference: PMID:18345000
reference_title: "A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Glycine 41, invariant throughout eukaryotes, is substituted by serine in a family with autosomal dominant thrombocytopenia caused by dysregulated platelet formation."
explanation: Identifies CYCS p.Gly41Ser as the original family variant associated with autosomal-dominant thrombocytopenia.
- name: CYCS p.His27Tyr
description: >-
A heterozygous CYCS missense variant reported in a large Chinese family
with autosomal-dominant non-syndromic thrombocytopenia 4.
gene:
preferred_term: CYCS
term:
id: hgnc:19986
label: CYCS
evidence:
- reference: PMID:35126455
reference_title: "A Novel Heterozygous Pathogenic Variation in CYCS Gene Cause Autosomal Dominant Non-Syndromic Thrombocytopenia 4 in a Large Chinese Family."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "A novel heterozygous missense variant c.79C > T (p.His27Tyr) was identified in CYCS gene associated with autosomal dominant thrombocytopenia."
explanation: Identifies p.His27Tyr as a CYCS variant associated with autosomal-dominant thrombocytopenia in a three-generation family.
features: >-
Heterozygous CYCS missense variants cause autosomal-dominant
thrombocytopenia 4. Reported pathogenic variants cluster in regions that
affect cytochrome c functions in apoptosis and mitochondrial respiration,
with variable severity of platelet count reduction.
treatments:
- name: Genetic Counseling
description: >-
Counseling for autosomal-dominant transmission and family testing where a
pathogenic CYCS variant has been identified.
treatment_term:
preferred_term: genetic counseling
term:
id: MAXO:0000079
label: genetic counseling
notes: >-
The seed label "mitochondrial cytochrome c deficiency" was not used as the
disease name because independent MONDO, OMIM, Orphanet, and PubMed evidence
identify OMIM:612004 / ORPHA:168629 as CYCS-related thrombocytopenia 4. This
entry therefore models the CYCS/cytochrome c mechanism leading to
thrombocytopenia and intentionally does not add CYCS to the mitochondrial
Complex IV deficiency grouping.